Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women, an Open Label Study With Dose Escalation

NCT02981459 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT02981459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02981459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women, an Open Label Study With Dose Escalation
Lead sponsor
State University of New York at Buffalo
Phase
Phase 4
Overall status
Withdrawn
Start date
December 8, 2017
Completion date
June 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder irritable, bladder pain syndrome, urinary frequency/urgency